KM Pharmaceutical Largest Shareholder Kang Il-mo Slightly Increases Stake to 39.34% via Open Market Purchase, Pledged Shares at 21.47%
KM Pharmaceutical's largest shareholder Kang Il-mo increased his stake from 39.32% to 39.34% by acquiring 1,490 shares via open market purchase on June 17, 2026.
The acquisition cost of approximately 3.05 million KRW was funded from personal employment income, representing a minor open market transaction with no dilution from new share issuance or convertible bonds.
Kang Il-mo maintains pledge agreements with IBK Investment & Securities 97,489 shares and Industrial Bank of Korea 1,100,000 shares, totaling 1,197,489 shares or 21.47% of total voting shares. Both loans have been extended with no immediate plans for further stake changes.
[AI Summary]The largest shareholder's small open market purchase may signal commitment but the negligible stake change and lack of capital allocation plans limit immediate stock price impact. However the 21.47% pledge ratio introduces potential margin call risk in case of price decline, warranting investor monitoring.